New findings out of Emory University are shaking theories of the origin of Alzheimer’s the leading cause of dementia among older adults worldwide.
The first study in the world, conducted recently at the University of Eastern Finland, demonstrates that even in those with a high hereditary risk, type [Read More…]
Recently, Japanese researchers discovered endolysin, an enzyme generated from bacteriophages that may attack Enterococcus faecalis biofilms. Their results provide promise for customized allo-HCT therapies.
A diagnosis of the underlying pathology is required for the development of therapies and for stratifying patients according to their disease.
When the medication was given to mice whose tumors had been surgically removed, similar results were also shown.
The drug is special, say the researchers, since it specifically targets the beta cells in the pancreas that produce insulin and is made to protect those cells against the immune system attacks.
Methylation of mRNA impairs the brain’s energy supply by interfering with the synthesis of ND5, a subunit of complex I of the respiratory chain.
Researchers at Umeå University demonstrate that a novel gene treatment has significantly slowed down the disease development in a patient with an extremely severe type of ALS illness.
On World Parkinson’s Day, a new hypothesis study combines the body-first and brain-first theories with environmental toxicants that may be consumed or breathed as potential origins of the condition.
This was a critical question and finding the answer opens up a whole new understanding of the link between this serious lung injury and the kind of inflammation that can lead to cardiovascular complications.
